FDA-Cited Recall Expands for Blood Pressure Medication Due to Dissolution Issues

A recall for chlorthalidone blood pressure medication has expanded after more pills failed to dissolve properly, an issue classified as Class II by the FDA, indicating a moderate risk. Approximately 13,567 bottles of 25 mg chlorthalidone tablets, manufactured by Inventia Healthcare Limited, were recalled due to failing dissolution specifications.